Molina Healthcare, Inc. income statement
In fiscal 2025, Molina Healthcare, Inc. reported revenue of $45.43bn, up 11.7% on the year before, operating income of $781m (a 1.7% margin) and net income of $472m, or $8.92 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.7 | 4.1 | 4.5 | 5.9 | 6.6 | 9.7 | 14.2 | 17.8 | 19.9 | 18.9 | 16.8 | 19.4 | 27.8 | 32.0 | 34.1 | 40.7 | 45.4 | 44.1 |
| Cost of revenue | — | — | — | — | — | — | — | — | — | — | 13.9 | 15.8 | 23.7 | 27.2 | 28.7 | 34.4 | 39.5 | 38.6 |
| Gross profit | — | — | — | — | 0.8 | 1.0 | 1.5 | 1.7 | 1.8 | 2.5 | 2.3 | 2.5 | 4.1 | 4.8 | 5.4 | 6.2 | 5.9 | 5.6 |
| General and administrative | 0.3 | 0.3 | 0.4 | 0.5 | 0.7 | 0.8 | 1.1 | 1.4 | 1.6 | 1.3 | 1.3 | 1.5 | 2.1 | 2.3 | 2.5 | 2.7 | 3.0 | 3.0 |
| Operating income | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.2 | 0.4 | 0.3 | −0.6 | 1.1 | 1.0 | 1.1 | 1.0 | 1.2 | 1.6 | 1.7 | 0.8 | 0.2 |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 |
| Income before tax | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.3 | 0.2 | −0.6 | 1.0 | 1.0 | 1.0 | 0.9 | 1.1 | 1.5 | 1.6 | 0.6 | −0.0 |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | −0.1 | 0.3 | 0.2 | 0.3 | 0.2 | 0.3 | 0.4 | 0.4 | 0.1 | 0.0 |
| Net income | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | −0.5 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 1.1 | 1.2 | 0.5 | −0.0 |
| Diluted EPS | $0.79 | $1.32 | $0.45 | $0.21 | $1.13 | $1.29 | $2.58 | $0.92 | −$9.07 | $10.61 | $11.47 | $11.23 | $11.25 | $13.55 | $18.77 | $20.42 | $8.92 | −$0.94 |
| Diluted shares (average) | 39m | 42m | 46m | 47m | 47m | 48m | 56m | 56m | 56m | 67m | 64m | 60m | 59m | 59m | 58m | 58m | 53m | 51m |
| EBITDA | 0.1 | 0.2 | 0.2 | 0.1 | 0.2 | 0.3 | 0.5 | 0.5 | −0.4 | 1.3 | 1.1 | 1.2 | 1.2 | 1.3 | 1.7 | 1.9 | 1.0 | 0.3 |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.5 | 11.1 | 11.4 | 11.5 | 11.4 | 10.8 | 10.9 | 11.1 |
| Cost of revenue | 9.0 | 9.5 | 9.8 | 10.0 | 10.1 | 9.3 | 9.4 | 9.7 |
| Gross profit | 1.5 | 1.7 | 1.6 | 1.4 | 1.2 | 1.5 | 1.4 | 1.4 |
| General and administrative | 0.7 | 0.8 | 0.7 | 0.7 | 0.8 | 0.8 | 0.7 | 0.7 |
| Operating income | 0.4 | 0.4 | 0.4 | 0.1 | −0.2 | 0.1 | 0.1 | 0.1 |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Income before tax | 0.3 | 0.4 | 0.3 | 0.1 | −0.2 | 0.0 | 0.1 | 0.1 |
| Income tax | 0.1 | 0.1 | 0.1 | 0.0 | −0.1 | 0.0 | 0.0 | 0.0 |
| Net income | 0.3 | 0.3 | 0.3 | 0.1 | −0.2 | 0.0 | 0.1 | 0.0 |
| Diluted EPS | $4.45 | $5.45 | $4.75 | $1.51 | −$2.87 | $0.27 | $1.19 | $0.73 |
| EBITDA | 0.4 | 0.5 | 0.4 | 0.2 | −0.1 | 0.1 | 0.2 | 0.1 |
Compare with peers
- Oscar Health, Inc. income statement
- Humana income statement
- Elevance Health income statement
- Centene Corporation income statement
- Alignment Healthcare, Inc. income statement
Head to head: MOH vs OSCRHUM vs MOHELV vs MOHALHC vs MOH
More: Managed Health Care stocks compared, Health Care sector, rankings of US companies